A detailed history of Manning & Napier Group, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Manning & Napier Group, LLC holds 271,786 shares of TAK stock, worth $3.69 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
271,786
Previous 297,886 8.76%
Holding current value
$3.69 Million
Previous $4.25 Million 11.18%
% of portfolio
0.04%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$13.89 - $15.04 $362,529 - $392,544
-26,100 Reduced 8.76%
271,786 $3.78 Million
Q4 2023

Jan 19, 2024

SELL
$13.36 - $15.43 $58,530 - $67,598
-4,381 Reduced 1.45%
297,886 $4.25 Million
Q3 2023

Oct 20, 2023

SELL
$15.03 - $16.32 $47,930 - $52,044
-3,189 Reduced 1.04%
302,267 $4.68 Million
Q2 2023

Jul 26, 2023

BUY
$15.57 - $17.11 $357,160 - $392,486
22,939 Added 8.12%
305,456 $4.8 Million
Q1 2023

Apr 17, 2023

SELL
$15.28 - $16.48 $116,830 - $126,006
-7,646 Reduced 2.64%
282,517 $4.66 Million
Q4 2022

Jan 26, 2023

SELL
$12.42 - $15.62 $68,844 - $86,581
-5,543 Reduced 1.87%
290,163 $0
Q3 2022

Oct 18, 2022

BUY
$12.8 - $28.65 $11,609 - $25,985
907 Added 0.31%
295,706 $3.84 Million
Q2 2022

Jul 12, 2022

BUY
$13.12 - $15.03 $44,568 - $51,056
3,397 Added 1.17%
294,799 $4.14 Million
Q1 2022

Apr 19, 2022

SELL
$13.54 - $15.35 $377,806 - $428,311
-27,903 Reduced 8.74%
291,402 $4.17 Million
Q4 2021

Jan 27, 2022

SELL
$13.17 - $16.4 $35,782 - $44,558
-2,717 Reduced 0.84%
319,305 $4.35 Million
Q3 2021

Oct 14, 2021

SELL
$16.3 - $17.26 $35,974 - $38,092
-2,207 Reduced 0.68%
322,022 $5.27 Million
Q2 2021

Jul 19, 2021

BUY
$16.55 - $18.64 $5.37 Million - $6.04 Million
324,229 New
324,229 $5.46 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Manning & Napier Group, LLC Portfolio

Follow Manning & Napier Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.